RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $131
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice TargetHot
RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target from $126 to $131.
RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target from $126 to $131.